NM_020962.3:c.3441C>G
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_020962.3(IGDCC4):c.3441C>G(p.Asp1147Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000106 in 1,605,692 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020962.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IGDCC4 | ENST00000352385.3 | c.3441C>G | p.Asp1147Glu | missense_variant | Exon 20 of 20 | 1 | NM_020962.3 | ENSP00000319623.3 | ||
IGDCC4 | ENST00000559327.1 | n.2710C>G | non_coding_transcript_exon_variant | Exon 14 of 14 | 1 | |||||
IGDCC4 | ENST00000558048.5 | n.573C>G | non_coding_transcript_exon_variant | Exon 3 of 3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152134Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000205 AC: 5AN: 243632 AF XY: 0.0000303 show subpopulations
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1453558Hom.: 0 Cov.: 35 AF XY: 0.0000138 AC XY: 10AN XY: 722662 show subpopulations
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152134Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74332 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.3441C>G (p.D1147E) alteration is located in exon 20 (coding exon 20) of the IGDCC4 gene. This alteration results from a C to G substitution at nucleotide position 3441, causing the aspartic acid (D) at amino acid position 1147 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at